Dr. Jaclyn Kay Robak, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4500 Sion Farm, Unit 2, Christiansted, VI 00820 Phone: 340-773-2020 Fax: 340-778-0977 |
Peter M Kumpitch, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Island Medical Center Sunny Isle, 4500 Sion Ferm, Christiansted, VI 00820 Phone: 340-778-4686 Fax: 340-778-0977 |
Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4500 Sion Farm, Unit #2, Christiansted, VI 00820 Phone: 340-773-2020 |
Dr. Lisa Ellen Adams, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Sterling Optical 3000 Golden Rock Shopping Center, Suite 14, Christiansted, VI 00820 Phone: 340-773-8880 Fax: 340-773-8433 |
Plessen Healthcare, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5 Orange Grove, Christiansted, VI 00820 Phone: 340-715-7720 Fax: 340-713-9002 |
Dr. Ria Amita Lutchmeesingh, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: Island Medical Center, Sunny Isle, Christiansted, VI 00823 Phone: 340-773-2020 |
Sterling Optical #680 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3000 Golden Rock Shopping Center, Suite 14 Sterling Optical, Christiansted, VI 00820 Phone: 340-773-8880 Fax: 340-773-8433 |
Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 4500 Sion Farm Unit #2, Christiansted, VI 00820 Phone: 340-773-2020 Fax: 340-778-0977 |
Dr. Carl Maschauer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4500 Sunny Isle, Christiansted, VI 00820 Phone: 302-381-2696 Fax: 340-778-0977 |
News Archive
The Global Network for Neglected Tropical Diseases' "End the Neglect" blog examines the fight against neglected tropical diseases (NTDs) in Burundi, writing, "In 2007, the Legatum Foundation, an international private investment organization that promotes sustainable development throughout the world agreed to fund the treatment of NTDs in Burundi and brought together several partners to assist Burundi's Ministry of Health."
Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the clinical study, SINGLE (ING114467), designed to support a new fixed-dose combination (FDC) therapy for the treatment of HIV.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.
Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.
› Verified 8 days ago